Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

AB Sciences decides against re-examination of masitinib filing

pharmatimesJune 06, 2018

Tag: AB Sciences , re-examination , masitinib filing

PharmaSources Customer Service